Stocklytics Platform
Asset logo for symbol ICUCW
LMF Acquisition Opportunities
ICUCW3
$0.04arrow_drop_down7.10%-$0.00
Penny Stock
Asset logo for symbol ICUCW
ICUCW3

$0.04

arrow_drop_down7.10%

Performance History

Chart placeholder
Key Stats
Open$0.04
Prev. Close$0.05
EPS-
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap-
PE Ratio-
LOWHIGH
Day Range0.04
0.04
52 Week Range0.00
0.34
Ratios
Revenue-
EBITDA Margin %-
EPS-

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About LMF Acquisition Opportunities (ICUCW)

SeaStar Medical Holding Corporation (ICUCW) is a leading medical technology company that specializes in innovative solutions for the healthcare industry. With a strong focus on research and development, SeaStar Medical is dedicated to providing state-of-the-art instruments and tools that improve patient outcomes and enhance clinical efficiency. The company's mission is to transform the way healthcare is delivered by harnessing the power of technology and innovation.
One of the key products offered by SeaStar Medical is the ICUCW instrument, which is designed to revolutionize the field of critical care. The ICUCW instrument combines advanced sensors, artificial intelligence, and machine learning algorithms to monitor and analyze vital signs in real-time. This allows healthcare professionals to make informed decisions and intervene early in critical situations, ultimately saving lives and improving patient outcomes.
Sector
Industry
CEO
Headquarters
Employees
0
Exchange
NASDAQ
add LMF Acquisition Opportunities  to watchlist

Keep an eye on LMF Acquisition Opportunities

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is LMF Acquisition Opportunities 's (ICUCW) price per share?

The current price per share for LMF Acquisition Opportunities (ICUCW) is $0.05. The stock has seen a price change of -$0 recently, indicating a -7.1% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for LMF Acquisition Opportunities (ICUCW)?

For LMF Acquisition Opportunities (ICUCW), the 52-week high is $0.35, which is 604.02% from the current price. The 52-week low is $0.01, the current price is 537.18% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is LMF Acquisition Opportunities (ICUCW) a growth stock?

LMF Acquisition Opportunities (ICUCW) has shown an average price growth of 0.41% over the past three years. It has received a score of 0 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying LMF Acquisition Opportunities as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is LMF Acquisition Opportunities (ICUCW) stock price performance year to date (YTD)?

As of the latest data, LMF Acquisition Opportunities (ICUCW) has a year-to-date price change of 55.8%. Over the past month, the stock has experienced a price change of -17.17%. Over the last three months, the change has been 9.71%. Over the past six months, the figure is -65.25%.
help

Is LMF Acquisition Opportunities (ICUCW) a profitable company?

LMF Acquisition Opportunities (ICUCW) has a net income of -$26.23M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$14.21M. Furthermore, the EBITDA is $0.
help

What is the market capitalization of LMF Acquisition Opportunities (ICUCW)?

LMF Acquisition Opportunities (ICUCW) has a market capitalization of . The average daily trading volume is 21.53K, indicating the stock's liquidity and investor engagement.

News

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against SeaStar Medical Holding Corporation (ICU)
SEASTAR MEDICAL HOLDING CORPORATION
CLASS ACTION LAWSUIT
HDE APPLICATION
FINANCIAL CONTROLS
8/20/2024

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against SeaStar Medical Holding Corporation (ICU)

ROSEN, LEADING INVESTOR COUNSEL, Encourages SeaStar Medical Holding Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – ICU
SEASTAR MEDICAL HOLDING CORPORATION
SECURITIES CLASS ACTION
COMPLIANCE CONTROLS
FINANCIAL REPORTING
REGULATORY PROSPECTS
8/19/2024

ROSEN, LEADING INVESTOR COUNSEL, Encourages SeaStar Medical Holding Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – ICU

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages SeaStar Medical Holding Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – ICU
SEASTAR MEDICAL HOLDING CORPORATION
SECURITIES CLASS ACTION
COMPLIANCE CONTROLS
FINANCIAL REPORTING
REGULATORY PROSPECTS
8/14/2024

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages SeaStar Medical Holding Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – ICU

ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages SeaStar Medical Holding Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – ICU
SEASTAR MEDICAL HOLDING CORPORATION
SECURITIES CLASS ACTION
COMPLIANCE CONTROLS
FINANCIAL REPORTING
REGULATORY PROSPECTS
8/10/2024

ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages SeaStar Medical Holding Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – ICU

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, SeaStar, and Bolt and Encourages Investors to Contact the Firm
CVS HEALTH CORPORATION
WALGREENS BOOTS ALLIANCE, INC.
SEASTAR MEDICAL HOLDING CORPORATION
BOLT BIOTHERAPEUTICS, INC.
8/7/2024

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS, Walgreens, SeaStar, and Bolt and Encourages Investors to Contact the Firm

ROSEN, A LONGSTANDING LAW FIRM, Encourages SeaStar Medical Holding Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – ICU
SEASTAR MEDICAL HOLDING CORPORATION
SECURITIES CLASS ACTION
COMPLIANCE CONTROLS
FINANCIAL REPORTING
REGULATORY PROSPECTS
8/6/2024

ROSEN, A LONGSTANDING LAW FIRM, Encourages SeaStar Medical Holding Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – ICU

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics.com All rights reserved.

Stocklytics.com is not a financial advisor, and all data and information provided on this website are for informational purposes only. The content on Stocklytics.com is not intended to be a substitute for professional financial advice. Investors should conduct their own research and consult with a qualified financial advisor before making any investment decisions. Stocklytics.com makes no representations or warranties regarding the accuracy, completeness, or suitability of any information provided and is not liable for any errors or omissions, or for any losses incurred as a result of reliance on the information provided on this website.

Stocklytics Discord public channelStocklytics X Social Media